|
|
CD45 Antibody, anti-non-human primate, PE-Vio 770, REAfinity 130-117-195 |
FCM
IF
IHC
Other
|
Hu
NHPr
|
PE-Vio 770
|
REA1023 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD45 Antibody, anti-non-human primate, PE-Vio 770, REAfinity 130-117-286 |
FCM
IF
IHC
Other
|
Hu
NHPr
|
PE-Vio 770
|
REA1023 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD61 Antibody, anti-mouse/rat, PE-Vio 770, REAfinity 130-122-151 |
FCM
IF
IHC
Other
|
Ms
Rt
|
PE-Vio 770
|
REA1192 |
30 µg in 200 µL |
¥20,100 |
|
|
|
CD90.1 Antibody, anti-mouse/rat, PE-Vio 770, REAfinity 130-112-686 |
FCM
IF
IHC
Other
|
Ms
Rt
|
PE-Vio 770
|
REA838 |
150 µg in 1 mL |
¥58,300 |
|
|
|
CD90.1 Antibody, anti-mouse/rat, PE-Vio 770, REAfinity 130-112-875 |
FCM
IF
IHC
Other
|
Ms
Rt
|
PE-Vio 770
|
REA838 |
30 µg in 200 µL |
¥20,100 |
|
|
|
CD49a Antibody, anti-mouse/rat, PE-Vio 770, REAfinity 130-123-892 |
FCM
IF
IHC
Other
|
Ms
Rt
|
PE-Vio 770
|
REA493 |
30 µg in 200 µL |
¥20,100 |
|
|
|
MHC Class II (I-Ek) Antibody, anti-mouse/rat, PE-Vio 770, REAfinity 130-107-875 |
FCM
IF
IHC
Other
|
Ms
Rt
|
PE-Vio 770
|
REA510 |
9 µg in 300 µL |
¥9,500 |
|
|
|
CD29 Antibody, anti-mouse, PE-Vio 770 130-105-125 |
FCM
IF
IHC
Other
|
Ms
Rt
|
PE-Vio 770
|
HMβ1-1 |
30 µg in 1 mL |
¥20,100 |
|
|
|
CD29 Antibody, anti-mouse/rat, PE-Vio 770, REAfinity 130-119-169 |
FCM
IF
IHC
Other
|
Ms
Rt
|
PE-Vio 770
|
REA1074 |
30 µg in 200 µL |
¥20,100 |
|
|
|
CD61 Antibody, anti-mouse/rat, PE-Vio 770 130-102-849 |
FCM
IF
IHC
Other
|
Ms
Rt
|
PE-Vio 770
|
2C9.G2 (HMβ3-1) |
9 µg in 300 µL |
¥9,500 |
|
|
|
MHC Class II (I-Ek) Antibody, anti-mouse/rat, PE-Vio 770, REAfinity 130-107-822 |
FCM
IF
IHC
Other
|
Ms
Rt
|
PE-Vio 770
|
REA510 |
30 µg in 1 mL |
¥20,100 |
|
|
|
CD61 Antibody, anti-mouse/rat, PE-Vio 770 130-102-627 |
FCM
IF
IHC
Other
|
Ms
Rt
|
PE-Vio 770
|
2C9.G2 (HMβ3-1) |
30 µg in 1 mL |
¥20,100 |
|
|
|
CD29 Antibody, anti-mouse, PE-Vio 770 130-105-186 |
FCM
IF
IHC
Other
|
Ms
Rt
|
PE-Vio 770
|
HMβ1-1 |
9 µg in 300 µL |
¥9,500 |
|
|
|
CD44 Antibody, anti-mouse, PE-Vio 770 130-102-904 |
FCM
IF
IHC
Other
|
NHPr
Ms
|
PE-Vio 770
|
IM7.8.1 |
9 µg in 300 µL |
¥9,500 |
|
|
|
CD44 Antibody, anti-mouse, PE-Vio 770 130-102-377 |
FCM
IF
IHC
Other
|
NHPr
Ms
|
PE-Vio 770
|
IM7.8.1 |
30 µg in 1 mL |
¥20,100 |
|
|
|
CD11b Antibody, anti-mouse, PE-Vio 770, REAfinity 130-113-808 |
FCM
IF
IHC
Other
|
Hu
NHPr
Ms
|
PE-Vio 770
|
REA592 |
30 µg in 200 µL |
¥20,100 |
|
|
|
CD11b Antibody, anti-mouse, PE-Vio 770, REAfinity 130-113-246 |
FCM
IF
IHC
Other
|
Hu
NHPr
Ms
|
PE-Vio 770
|
REA592 |
150 µg in 1 mL |
¥58,300 |
|
|
|
CD48 Antibody, anti-mouse, PE-Vio 770 130-102-363 |
FCM
FA
IF
IHC
Other
|
Ms
|
PE-Vio 770
|
HM48-1 |
30 µg in 1 mL |
¥20,100 |
|
|
|
CD115 Antibody, anti-mouse, PE-Vio 770 130-103-962 |
FCM
IF
IHC
Other
|
Ms
|
PE-Vio 770
|
AFS98 |
30 µg in 1 mL |
¥20,100 |
|
|
|
CD150 (SLAM) Antibody, anti-mouse, PE-Vio 770, REAfinity 130-126-108 |
FCM
IF
IHC
Other
|
Ms
|
PE-Vio 770
|
REA299 |
30 µg in 200 µL |
¥20,100 |
|